Arginine

Category
amino acid
Half-Life (t½)
PO: 1.7h · IV: 1.7h
Formula
C6H14N4O2
Molecular Weight
174.2 g/mol
PubChem CID
6322
Aliases
Arg, R, L-Arginine

Pharmacological Mechanism

Substrate for nitric oxide synthesis NOS → endothelial NO → vasodilation. Intermediate in the urea cycle. Precursor to creatine (with glycine and methionine), polyamines (via ornithine), and proline. Oral F limited by saturable CAT-1 transport and first-pass hepatic arginase activity.

Half-Life & Elimination Curve (PO: 1.7h · IV: 1.7h)

100%50%25%12.5%0%0h0×t½1.7h1×t½3.4h2×t½5.1h3×t½6.8h4×t½8.5h5×t½0×t½ (0h): 100% remaining (~59.7 mg/L)1×t½ (1.7h): 50% remaining (~29.9 mg/L)2×t½ (3.4h): 25% remaining (~14.9 mg/L)3×t½ (5.1h): 12.5% remaining (~7.47 mg/L)4×t½ (6.8h): 6.3% remaining (~3.73 mg/L)5×t½ (8.5h): 3.1% remaining (~1.87 mg/L)
Plasma (PO)t½ Decay (1.7h)
  • 0×t½0h100% (59.7 mg/L)
  • 1×t½1.7h50% (29.9 mg/L)
  • 2×t½3.4h25% (14.9 mg/L)
  • 3×t½5.1h12.5% (7.47 mg/L)
  • 4×t½6.8h6.3% (3.73 mg/L)
  • 5×t½8.5h3.1% (1.87 mg/L)
Elimination t½1.7h (PO)
Rate Constant (ke)0.408 h⁻¹
Time to Peak (Tmax)1.19h
Est. Peak (Cmax)59.7 mg/L
Clearance (CL)11.4 L/h
97% Washout (5×t½)8.5h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Top Dietary Sources

Chemical Structure & Identifiers

References